[1]
“Clinical evaluation in adult human revealed the biosimilarity of recombinant Erythropoietin GBPD002 with Eprex®”, acbr, vol. 7, no. 4, pp. 459–474, Aug. 2023, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/15029